Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shumo Cai
Addition of Intraperitoneal Cisplatin and Etoposide to First-Line Chemotherapy for Advanced Ovarian Cancer: A Randomised, Phase 2 Trial
British Journal of Cancer
Cancer Research
Oncology
Related publications
Treatment of Metastatic Germ Cell Tumors With Etoposide and Cisplatin as First Line Chemotherapy
Japanese Journal of Urology
Urology
PROFAST: ERAS in Advanced Ovarian Cancer, a Randomised Trial
Clinical Nutrition ESPEN
Endocrinology
Nutrition
Metabolism
Dietetics
Diabetes
Neoadjuvant, Adjuvant and Long-Term Intravenous/Intraperitoneal Chemotherapy, Hyperthermic Intraperitoneal Chemotherapy, Early Postoperative Intraperitoneal Chemotherapy for Ovarian Cancer
Journal of Peritoneum (and other serosal surfaces)
Is Peritonectomy and Hyperthermic Intraperitoneal Chemotherapy a New Standard of Treatment for Advanced Epithelial Ovarian Cancer?
Australian and New Zealand Journal of Obstetrics and Gynaecology
Medicine
Gynecology
Obstetrics
Hyperthermic Intraperitoneal Chemotherapy Does Not Improve Survival in Advanced Ovarian Cancer
Cancer
Cancer Research
Oncology
G08Feasibility and Tolerability of Intraperitoneal Chemotherapy in Ovarian Cancer
Annals of Oncology
Medicine
Oncology
Hematology
Randomized Phase III Trial of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients With Extensive-Disease Small Cell Lung Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma
Anticancer Research
Medicine
Cancer Research
Oncology
Intraperitoneal Chemotherapy in Ovarian Cancer: A Review of Tolerance and Efficacy
Cancer Management and Research
Oncology
